Question 1

What are the potential side effects of CHF 5993?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. clinical trial (NCT02040597). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my kidney function be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. clinical trial (NCT02040597). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I expect during the treatment visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. clinical trial (NCT02040597). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this treatment compare to my current COPD management?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. clinical trial (NCT02040597). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. clinical trial (NCT02040597). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects while in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. clinical trial (NCT02040597). Contact the study team or your healthcare provider for specific answers.

What this study is about